NCAM1 and depressive symptom measurement: Key populations implicated include classical and non-classical monocytes (CD14, CD16), NK cell subsets (CD56, CD16), and granulocytes (CD15, CD16), all of which have been shown to be altered in individuals with depression, particularly in inflammation-associated subtypes (Miller and Raison, 2016).